Alliance Pharma PLC Director Share Dealing (1014H)

TIDMAPH

RNS Number : 1014H

Alliance Pharma PLC

12 November 2018

12 November 2018

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Director Share Dealing

Alliance Pharma plc (AIM: APH), the international specialty pharmaceutical group, announces that it was notified on 9 November 2018 that, on the same day, John Dawson, Non-Executive Director, sold 1,100,000 ordinary shares of 1 pence each in the Company at a price of 70.1 pence per share.

Following this transaction, Mr Dawson's total interest in the Company is 55,476,402 ordinary shares, representing approximately 10.71 per cent of the Company's current issued share capital (comprised of a total beneficial interest in 35,476,402 Ordinary Shares, representing 6.85 per cent of the issued share capital, and a total non-beneficial interest in 20,000,000 Ordinary Shares, representing 3.86 per cent of the issued share capital).

For further information:

 
 Alliance Pharma plc                          + 44 (0)1249 466966 
 Peter Butterfield, Chief Executive 
  Officer 
 Andrew Franklin, Chief Financial Officer 
 www.alliancepharma.co.uk 
 Buchanan                                    + 44 (0)20 7466 5000 
 Mark Court / Sophie Wills / Gemma 
  Mostyn-Owen 
 
 Numis Securities Limited                    + 44 (0)20 7260 1000 
 Nominated Adviser: Michael Meade / 
  Freddie Barnfield 
 Corporate Broking: James Black 
 
 
 Investec Bank plc                    + 44 (0) 20 7597 5970 
 Corporate Finance: Daniel Adams / 
  Ed Thomas 
 Corporate Broking: Patrick Robb / 
  David Herring 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
 a)    Name                         Mr John Dawson 
      ---------------------------  ------------------------------------ 
 2     Reason for the notification 
      ----------------------------------------------------------------- 
 a)    Position/status              Non-Executive Director 
      ---------------------------  ------------------------------------ 
 b)    Initial notification         Initial Notification 
        /Amendment 
      ---------------------------  ------------------------------------ 
 3     Details of the issuer, emission allowance market 
        participant, auction platform, auctioneer or 
        auction monitor 
      ----------------------------------------------------------------- 
 a)    Name                         Alliance Pharma plc 
      ---------------------------  ------------------------------------ 
 b)    Legal Entity                 213800RYIWZA4Q5WPZ13 
        Identifier 
      ---------------------------  ------------------------------------ 
 4     Details of the transaction(s): section to be 
        repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and 
        (iv) each place where transactions have been 
        conducted 
      ----------------------------------------------------------------- 
 a)    Description                  Ordinary shares of 1.0 pence each 
        of the financial             ISIN: GB0031030819 
        instrument, 
        type of instrument 
        Identification 
        code 
      ---------------------------  ------------------------------------ 
 b)    Nature of the                Sale of shares 
        transaction 
      ---------------------------  ------------------------------------ 
 c)    Currency                     GBP 
      ---------------------------  ------------------------------------ 
 d)    Price(s) and                     Price (p)          Volume(s) 
        volume(s) 
      ---------------------------  ------------------  ---------------- 
                                          70.1p            1,100,000 
 --------------------------------  ------------------  ---------------- 
 
 e)    Aggregated                    1,100,000 ordinary shares 
        information                   70.1p 
        - Aggregated                  GBP770,720.01 
        volume 
        - Price 
        - Aggregated 
        total 
      ---------------------------  ------------------------------------ 
 f)    Date of the                  9 November 2018 
        transaction 
      ---------------------------  ------------------------------------ 
 g)    Place of the                 London Stock Exchange, AIM 
        transaction 
      ---------------------------  ------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKBDQPBDDFDD

(END) Dow Jones Newswires

November 12, 2018 10:51 ET (15:51 GMT)